David J. Brailer - 22 Feb 2023 Form 4 Insider Report for Cigna Group (CI)

Role
EVP & Chief Health Officer
Signature
Kevin Ciaglo, attorney-in-fact
Issuer symbol
CI
Transactions as of
22 Feb 2023
Net transactions value
$0
Form type
4
Filing time
24 Feb 2023, 20:12:06 UTC
Previous filing
06 Sep 2022
Next filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +3,395 +194% $0.000000 5,144 22 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +12,544 $0.000000 12,544 22 Feb 2023 Common Stock, $.01 Par Value 12,544 $294.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2024.
F2 This option vests in three equal annual installments beginning March 1, 2024.

Remarks:

Exhibit List: EX-24 Power of Attorney poabrailer.txt